Medgenics Announces Exercise by Underwriters of Over-Allotment Option

With the exercise of this over-allotment option, the net proceeds to Medgenics from the initial public offering are approximately $10.2 million, after deducting underwriting discounts and commissions and offering expenses payable by the Company. …
See all stories on this topic »